Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment

Ann Intern Med. 2021 Mar;174(3):431-432. doi: 10.7326/L20-1455.
No abstract available

Publication types

  • Comment

MeSH terms

  • Canagliflozin* / adverse effects
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Myotoxicity
  • Rosuvastatin Calcium / adverse effects

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Canagliflozin
  • Rosuvastatin Calcium